May Report Links JIC’s JSR Sale Review to Surge in Semiconductor Valuations
Key Facts
The reported sale of JSR to Mitsui Chemicals and the deal value could not be verified in a credible open source for the story date, so no confirmed details are available about a new sale on November 4. In a report published on May 28, 2026, Reuters said sources indicated that Japan Investment Corporation (JIC) was considering selling the company about two years after taking it private in a deal valued at $6 billion. The report said Fujifilm and Mitsubishi Chemical were interested in acquiring it, without identifying a final buyer or a completed agreement. The report covered sale options at the time; it was not an announcement that a deal had closed. The $6 billion figure therefore relates to the earlier transaction that took JSR private, not a confirmed price for a possible new sale.
JSR is a leading manufacturer of photoresists, materials used to transfer circuit patterns onto semiconductor chips. This business places the company in the semiconductor supply chain, where valuations have risen as spending on artificial intelligence has expanded. Reuters’ May report linked JIC’s sale review to this market shift, saying heavy investment in AI had lifted valuations of chip suppliers. The report said the surge in valuations could allow the fund to consider exiting its investment. This context, however, does not establish that a new sale decision was made in November or set terms for a possible deal.
In June 2026, JIC said it had not decided how to exit JSR, whether through an initial public offering or a sale. The fund added that it would first work to increase the company’s value before deciding on an exit route. At the same conference, JIC’s chairman said the company’s performance was at record levels, supported by strength in its semiconductor business and a return to profitability in its U.S. life sciences business. The new chairman linked the market’s improvement to rising demand for AI data centers. These comments show that the fund was prioritizing increasing the company’s value before settling on an exit, without announcing a timetable or final structure.
JSR reported net profit of 60.7 billion yen and revenue of 400.7 billion yen for the year ended March 2026, according to Reuters. The company returned to profitability after its life sciences business weighed on results in the previous year, the report said. These figures come amid operating performance that JIC’s chairman described in June as being at record levels, with strength in semiconductor operations and an improvement in U.S. life sciences. The report does not say whether the results or this improvement changed the exit decision. It also does not provide a current company valuation or a potential sale price.
In its May report, Reuters cited shares of Tokyo Ohka Kogyo, a competitor in photoresist manufacturing, as an example of rising valuations among semiconductor materials companies: its share price had tripled over the previous year, and its market capitalization stood at 1.4 trillion yen on May 28, 2026. As for the market reaction at the time, Fujifilm shares ended the May 28 session up 3%, while Mitsubishi Chemical shares pared losses and closed nearly flat after the report of acquisition interest was published. The share moves relate to that session and the prospective buyers covered in the May report. The available evidence provides no information about the market reaction on November 4 or any subsequent progress in sale discussions.